SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?


To: Maxer who wrote (269)7/17/1998 5:14:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 642
 
This is from Bloomberg:

Eli Lilly & Co. (LLY) rose as much as 2 15/16 to 67 3/8 as
the pharmaceutical company was rated a new ''buy'' by analyst C.
Anthony Butler at Lehman Brothers Inc. Butler said he expects the
company's earnings to grow in the near-term from its currently
marketed drugs, while long-term growth will come from four
diabetes drugs in its development pipeline.